Lactulose Eg (Lactulose)

Lactulose is a synthetic sugar that reaches the colon unchanged. Colonic bacteria break it down into short‑chain fatty acids, which increase the osmotic pressure in the intestinal lumen. This draws water into the bowel, softening stool and stimulating peristalsis. The resulting acidic environment also converts ammonia to ammonium, trapping it for excretion and reducing systemic ammonia levels.

The appropriate dose of Lactulose Eg is individualized by the prescribing healthcare professional based on the patient’s condition, severity of symptoms, age, renal and hepatic function, and response to therapy. Dosage may be adjusted over time to achieve the desired clinical effect while minimizing side effects.

Safety data for Lactulose in pregnancy and lactation are limited. It is generally categorized as a drug to be used only if the potential benefit justifies the potential risk to the fetus or infant. Healthcare providers should evaluate the risk‑benefit profile for each patient and discuss alternatives when appropriate.

To order Lactulose Eg, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any temperature requirements) and assist with import documentation.

Lactulose belongs to the osmotic laxative class, differing from stimulant laxatives (e.g., bisacodyl) that increase intestinal motility, and bulk‑forming agents (e.g., psyllium) that add fiber. Osmotic agents like Lactulose draw water into the colon, providing a gentler, stool‑softening effect and, uniquely, the ability to lower ammonia levels, making it useful for hepatic encephalopathy—a benefit not shared by most other laxatives.

Lactulose should be stored at ambient temperature, preferably below 25 °C, in its original container. The container should be kept tightly closed, protected from moisture and direct sunlight. No special refrigeration is required for the oral solution form, but it should be kept out of reach of children.

Lactulose is administered orally, typically as a liquid solution that can be taken directly or mixed with water or another suitable beverage. The exact volume and frequency are determined by the prescribing clinician, who will tailor the regimen to achieve the desired therapeutic effect while monitoring tolerance.

Serious risks include severe electrolyte disturbances (such as hyponatremia or hypokalemia), dehydration, and rare allergic reactions that may present as rash, urticaria, or anaphylaxis. In extreme cases, excessive fluid loss can lead to hypovolemia or, very rarely, colonic perforation, especially in patients with pre‑existing intestinal obstruction.

Lactulose should be avoided in individuals with known intestinal obstruction, perforated bowel, or severe inflammatory bowel disease. Patients with hypersensitivity to Lactulose or any of its excipients should not use the product. Caution is also advised for those with severe renal impairment or uncontrolled diabetes, and use should be guided by a healthcare professional.